NCT02989623View on ClinicalTrials.gov

Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

April 24, 2019

Study Completion Date

April 25, 2019

Conditions
Prostate Cancer
Interventions
RADIATION

Copper Cu 64 TP3805

Given Intravenously

PROCEDURE

Positron Emission Tomography and Computed Tomography Scan

Undergo copper Cu 64 TP3805 PET/CT scan

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT02989623 - Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA | Biotech Hunter | Biotech Hunter